{"transactions":[{"id":4634980,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:30:24.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":993,"price":12.21,"value":12124.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2026."}],"balance_after":132004,"source":{"system":"sec-edgar","filing":"0001193125-26-412424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526412424/ownership.xml","form_type":"4"}},{"id":4632441,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-10-01T21:23:04.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":7679,"price":2.93,"value":22499.47,"ownership":{"direct":true},"balance_after":239836,"source":{"system":"sec-edgar","filing":"0001161697-26-000222","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000222/form_4.xml","form_type":"4"}},{"id":714895,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:05:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":662,"price":17.84,"value":11810.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2026."}],"balance_after":131011,"source":{"system":"sec-edgar","filing":"0001193125-26-296615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526296615/ownership.xml","form_type":"4"}},{"id":722233,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-07-01T21:18:11.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":5357,"price":4.2,"value":22499.4,"ownership":{"direct":true},"balance_after":232157,"source":{"system":"sec-edgar","filing":"0001161697-26-000145","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000145/form_4.xml","form_type":"4"}},{"id":763508,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-26T20:30:07.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":12820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders."}],"balance_after":12820,"derivative":{"underlying":"Common Stock","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001193125-26-239427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526239427/ownership.xml","form_type":"4"}},{"id":767718,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-21T20:30:18.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":false,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0001193125-26-234574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526234574/ownership.xml","form_type":"4"}},{"id":767717,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T20:30:18.000Z","date":"2026-05-19","kind":"exercise","planned":false,"acquired":true,"shares":12417,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i)\nthe first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their\nscheduled vesting date."}],"balance_after":130349,"source":{"system":"sec-edgar","filing":"0001193125-26-234574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526234574/ownership.xml","form_type":"4"}},{"id":819276,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T18:53:59.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":1270,"price":9.1,"value":11557.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026."}],"balance_after":117932,"source":{"system":"sec-edgar","filing":"0001193125-26-139797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526139797/ownership.xml","form_type":"4"}},{"id":823666,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-04-01T20:48:11.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":5208,"price":4.32,"value":22498.56,"ownership":{"direct":true},"balance_after":226800,"source":{"system":"sec-edgar","filing":"0001161697-26-000081","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000081/form_4.xml","form_type":"4"}},{"id":950728,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T23:40:40.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":422,"price":13.68,"value":5772.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2025."}],"balance_after":116662,"source":{"system":"sec-edgar","filing":"0001193125-26-002922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526002922/ownership.xml","form_type":"4"}},{"id":956001,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2026-01-02T23:51:33.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3872,"price":5.81,"value":22496.32,"ownership":{"direct":true},"balance_after":221592,"source":{"system":"sec-edgar","filing":"0001161697-26-000010","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000010/form_4.xml","form_type":"4"}},{"id":1026745,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T23:09:53.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":265,"price":21.79,"value":5774.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2025."}],"balance_after":116240,"source":{"system":"sec-edgar","filing":"0001193125-25-228835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525228835/ownership.xml","form_type":"4"}},{"id":1028621,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-10-02T20:36:21.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":5874,"price":3.83,"value":22497.42,"ownership":{"direct":true},"balance_after":217720,"source":{"system":"sec-edgar","filing":"0001161697-25-000334","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000334/form_4.xml","form_type":"4"}},{"id":1096927,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-07-02T20:50:34.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":6284,"price":3.58,"value":22496.72,"ownership":{"direct":true},"balance_after":211846,"source":{"system":"sec-edgar","filing":"0001161697-25-000198","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000198/form_4.xml","form_type":"4"}},{"id":1094676,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:45:34.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":484,"price":11.94,"value":5778.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2025."}],"balance_after":115975,"source":{"system":"sec-edgar","filing":"0000950170-25-093109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025093109/ownership.xml","form_type":"4"}},{"id":1135061,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-23T22:22:24.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":12417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders."}],"balance_after":12417,"derivative":{"underlying":"Common Stock","underlying_shares":12417},"source":{"system":"sec-edgar","filing":"0000950170-25-077201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025077201/ownership.xml","form_type":"4"}},{"id":1138974,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-21T09:26:21.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2025, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Paratek Pharmaceuticals, Inc., a Delaware corporation (\"Parent\"), and Orca Merger Sub, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the terms of the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the \"Effective Time')."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $9.00 in cash, without interest (the \"Cash Consideration\") and (ii) one contractual contingent value right (\"CVR\") per share representing the right to receive two contingent payments of up to $5.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent and Equiniti Trust Company, LLC, as rights agent."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."}],"balance_after":0,"derivative":{"exercise_price":33.75,"expiration_date":"2032-04-26","underlying":"Common Stock","underlying_shares":4266},"source":{"system":"sec-edgar","filing":"0001104659-25-051348","document":"tm2515648-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000110465925051348/tm2515648-4_4seq1.xml","form_type":"4"}},{"id":1138973,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-21T09:26:21.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2025, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Paratek Pharmaceuticals, Inc., a Delaware corporation (\"Parent\"), and Orca Merger Sub, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the terms of the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the \"Effective Time')."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $9.00 in cash, without interest (the \"Cash Consideration\") and (ii) one contractual contingent value right (\"CVR\") per share representing the right to receive two contingent payments of up to $5.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent and Equiniti Trust Company, LLC, as rights agent."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."}],"balance_after":0,"derivative":{"exercise_price":17.7,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":3566},"source":{"system":"sec-edgar","filing":"0001104659-25-051348","document":"tm2515648-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000110465925051348/tm2515648-4_4seq1.xml","form_type":"4"}},{"id":1138972,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-21T09:26:21.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 19, 2025, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Paratek Pharmaceuticals, Inc., a Delaware corporation (\"Parent\"), and Orca Merger Sub, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the terms of the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the \"Effective Time')."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $9.00 in cash, without interest (the \"Cash Consideration\") and (ii) one contractual contingent value right (\"CVR\") per share representing the right to receive two contingent payments of up to $5.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent and Equiniti Trust Company, LLC, as rights agent."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised stock option, whether vested or unvested, was converted into the right to receive (i) an amount in cash, without interest, equal to the excess, if any of (A) the Cash Consideration over (B) the exercise price per share of such stock option; provided that, (1) each stock option with an exercise price per share that is greater than $14.00 (the sum of the Cash Consideration and the maximum amount payable under the CVR) was cancelled for no consideration and (2) each stock option with an exercise price per share that is greater than the amount of the Cash Consideration but less than $14.00 was canceled and converted into the right to receive one CVR with the amount payable pursuant to such CVR, if any, reduced by the amount by which the exercise price per share of such stock option exceeds the Cash Consideration)."}],"balance_after":0,"derivative":{"exercise_price":15.6,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":5666},"source":{"system":"sec-edgar","filing":"0001104659-25-051348","document":"tm2515648-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000110465925051348/tm2515648-4_4seq1.xml","form_type":"4"}},{"id":1142378,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-19T21:01:30.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":false,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0000950170-25-074519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025074519/ownership.xml","form_type":"4"}},{"id":1142377,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:01:30.000Z","date":"2025-05-16","kind":"exercise","planned":false,"acquired":true,"shares":21093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":115491,"source":{"system":"sec-edgar","filing":"0000950170-25-074519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025074519/ownership.xml","form_type":"4"}},{"id":1182974,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T00:23:54.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":486,"price":11.89,"value":5778.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2025."}],"balance_after":94398,"source":{"system":"sec-edgar","filing":"0000950170-25-049823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025049823/ownership.xml","form_type":"4"}},{"id":1185443,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-04-02T20:29:31.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":8806,"price":2.56,"value":22543.36,"ownership":{"direct":true},"balance_after":205562,"source":{"system":"sec-edgar","filing":"0001161697-25-000132","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000132/form_4.xml","form_type":"4"}},{"id":1314127,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:48:48.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":375,"price":15.38,"value":5767.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2024."}],"balance_after":93912,"source":{"system":"sec-edgar","filing":"0000950170-25-001298","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025001298/ownership.xml","form_type":"4"}},{"id":1317603,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2025-01-03T21:29:12.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":5905,"price":3.81,"value":22498.05,"ownership":{"direct":true},"balance_after":196756,"source":{"system":"sec-edgar","filing":"0001161697-25-000019","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000019/form_4.xml","form_type":"4"}},{"id":1393998,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:22:03.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":515,"price":11.21,"value":5773.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2024."}],"balance_after":93537,"source":{"system":"sec-edgar","filing":"0001285550-24-000112","document":"wk-form4_1727900515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000112/wk-form4_1727900515.xml","form_type":"4"}},{"id":1397515,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-10-01T20:04:01.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":8181,"price":2.75,"value":22497.75,"ownership":{"direct":true},"balance_after":190851,"source":{"system":"sec-edgar","filing":"0001161697-24-000405","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000405/form_4.xml","form_type":"4"}},{"id":1455667,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-07-12T14:41:33.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":8371,"price":2.71,"value":22685.41,"ownership":{"direct":true},"balance_after":182670,"source":{"system":"sec-edgar","filing":"0001161697-24-000307","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000307/form_4.xml","form_type":"4"}},{"id":1462497,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T21:20:58.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1072,"price":5.39,"value":5778.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 28, 2024."}],"balance_after":93022,"source":{"system":"sec-edgar","filing":"0001285550-24-000085","document":"wk-form4_1719955251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000085/wk-form4_1719955251.xml","form_type":"4"}},{"id":1486708,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T16:27:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 6, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":85000,"derivative":{"exercise_price":1.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001494650-24-000091","document":"wk-form4_1717792022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000149465024000091/wk-form4_1717792022.xml","form_type":"4"}},{"id":1510994,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-17T20:21:48.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":21093,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders."}],"balance_after":21093,"derivative":{"underlying":"Common Stock","underlying_shares":21093},"source":{"system":"sec-edgar","filing":"0001285550-24-000066","document":"wk-form4_1715977289.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000066/wk-form4_1715977289.xml","form_type":"4"}},{"id":1515801,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-15T13:20:45.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-24-000058","document":"wk-form4_1715779234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000058/wk-form4_1715779234.xml","form_type":"4"}},{"id":1515800,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T13:20:45.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":17153,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":91950,"source":{"system":"sec-edgar","filing":"0001285550-24-000058","document":"wk-form4_1715779234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000058/wk-form4_1715779234.xml","form_type":"4"}},{"id":1553074,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T20:44:09.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":850,"price":6.8,"value":5780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 28, 2024."}],"balance_after":74797,"source":{"system":"sec-edgar","filing":"0001285550-24-000043","document":"wk-form4_1712090634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000043/wk-form4_1712090634.xml","form_type":"4"}},{"id":1557148,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-04-01T20:10:18.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":9493,"price":2.37,"value":22498.41,"ownership":{"direct":true},"balance_after":174353,"source":{"system":"sec-edgar","filing":"0001161697-24-000168","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000168/form_4.xml","form_type":"4"}},{"id":1691611,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T16:56:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":851,"price":6.79,"value":5778.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 29, 2023."}],"balance_after":73947,"source":{"system":"sec-edgar","filing":"0001285550-24-000004","document":"wk-form4_1704300979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000004/wk-form4_1704300979.xml","form_type":"4"}},{"id":1697430,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2024-01-02T21:48:40.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":9493,"price":2.37,"value":22498.41,"ownership":{"direct":true},"balance_after":164860,"source":{"system":"sec-edgar","filing":"0001161697-24-000007","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000007/form_4.xml","form_type":"4"}},{"id":1769484,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-10-03T20:16:14.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":8226,"price":2.74,"value":22539.24,"ownership":{"direct":true},"balance_after":155367,"source":{"system":"sec-edgar","filing":"0001161697-23-000516","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000516/form_4.xml","form_type":"4"}},{"id":1766987,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T16:41:30.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":1153,"price":5.01,"value":5776.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2023."}],"balance_after":73096,"source":{"system":"sec-edgar","filing":"0001285550-23-000105","document":"wf-form4_169635127726527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000105/wf-form4_169635127726527.xml","form_type":"4"}},{"id":1835649,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:46:45.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":798,"price":7.24,"value":5777.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 30, 2023."}],"balance_after":71943,"source":{"system":"sec-edgar","filing":"0001285550-23-000080","document":"wf-form4_168859358344306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000080/wf-form4_168859358344306.xml","form_type":"4"}},{"id":1838485,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-07-05T20:12:18.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":6465,"price":3.48,"value":22498.2,"ownership":{"direct":true},"balance_after":147141,"source":{"system":"sec-edgar","filing":"0001161697-23-000390","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000390/form_4.xml","form_type":"4"}},{"id":1860459,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T14:06:44.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":53500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 8, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":53500,"derivative":{"exercise_price":1.18,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":53500},"source":{"system":"sec-edgar","filing":"0001494650-23-000059","document":"wk-form4_1686333996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000149465023000059/wk-form4_1686333996.xml","form_type":"4"}},{"id":1876233,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-26T18:10:58.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":17153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders."}],"balance_after":17153,"derivative":{"underlying":"Common Stock","underlying_shares":17153},"source":{"system":"sec-edgar","filing":"0001285550-23-000061","document":"wf-form4_168512464277542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000061/wf-form4_168512464277542.xml","form_type":"4"}},{"id":1926104,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-04-05T20:06:05.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":5281,"price":4.26,"value":22497.06,"ownership":{"direct":true},"balance_after":140676,"source":{"system":"sec-edgar","filing":"0001161697-23-000233","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000233/form_4.xml","form_type":"4/A","original_submission_date":"2023-04-03"}},{"id":1927495,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:57:19.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":684,"price":8.44,"value":5772.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2023."}],"balance_after":71145,"source":{"system":"sec-edgar","filing":"0001285550-23-000038","document":"wf-form4_168064182283698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000038/wf-form4_168064182283698.xml","form_type":"4"}},{"id":1933375,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-04-03T20:04:22.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":5281,"price":4.26,"value":22497.06,"ownership":{"direct":true},"balance_after":140380,"source":{"system":"sec-edgar","filing":"0001161697-23-000213","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000213/form_4.xml","form_type":"4"}},{"id":2050588,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-01-19T21:30:17.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":4368,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 4,368 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 4,368 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."}],"balance_after":23895,"source":{"system":"sec-edgar","filing":"0001493152-23-001919","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315223001919/ownership.xml","form_type":"4"}},{"id":2066579,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T22:58:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":2175,"price":7.97,"value":17334.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $7.97 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending December 30, 2022."}],"balance_after":70461,"source":{"system":"sec-edgar","filing":"0001285550-23-000006","document":"wf-form4_167287309071574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000006/wf-form4_167287309071574.xml","form_type":"4"}},{"id":2073704,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2023-01-03T21:46:34.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":6410,"price":3.51,"value":22499.1,"ownership":{"direct":true},"balance_after":135395,"source":{"system":"sec-edgar","filing":"0001161697-23-000023","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000023/form_4.xml","form_type":"4"}},{"id":2134531,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-10-19T13:00:15.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":8290,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 8,290 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 8,290 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":97649,"source":{"system":"sec-edgar","filing":"0001493152-22-028715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222028715/ownership.xml","form_type":"4"}},{"id":2144114,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T22:17:40.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":1702,"price":10.19,"value":17343.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $10.19 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending September 30, 2022."}],"balance_after":68286,"source":{"system":"sec-edgar","filing":"0001285550-22-000063","document":"wf-form4_166492184686141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000063/wf-form4_166492184686141.xml","form_type":"4"}},{"id":2148273,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-10-03T20:51:46.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":10022,"price":2.25,"value":22549.5,"ownership":{"direct":true},"balance_after":128985,"source":{"system":"sec-edgar","filing":"0001161697-22-000493","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000493/form_4.xml","form_type":"4"}},{"id":2200052,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-07-29T20:56:51.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":4696,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 4,696 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 4,696 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":89359,"source":{"system":"sec-edgar","filing":"0001493152-22-020756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222020756/ownership.xml","form_type":"4"}},{"id":2211654,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-06T18:38:10.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":1373,"price":12.63,"value":17340.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $12.63 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ending June 30, 2022."}],"balance_after":66584,"source":{"system":"sec-edgar","filing":"0001285550-22-000031","document":"wf-form4_165713267692568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000031/wf-form4_165713267692568.xml","form_type":"4"}},{"id":2216052,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-07-05T22:13:07.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":9003,"price":2.5,"value":22507.5,"ownership":{"direct":true},"balance_after":118963,"source":{"system":"sec-edgar","filing":"0001161697-22-000338","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000338/form_4.xml","form_type":"4"}},{"id":2253088,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-05-27T20:36:43.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":6179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":6179,"derivative":{"exercise_price":9.71,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":6179},"source":{"system":"sec-edgar","filing":"0001420506-22-001145","document":"doc4_1008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050622001145/doc4_1008.xml","form_type":"4"}},{"id":2253087,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:36:43.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":9269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders."}],"balance_after":65211,"source":{"system":"sec-edgar","filing":"0001420506-22-001145","document":"doc4_1008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050622001145/doc4_1008.xml","form_type":"4"}},{"id":2290669,"issuer":{"id":79464,"kind":"organization","name":"OptiNose, Inc.","symbol":"OPTN"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-26T16:16:40.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a three-year period commencing on April 26, 2022. Thirty-three percent (33%) of the option vests and becomes exercisable on April 26, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer."}],"balance_after":64000,"derivative":{"exercise_price":2.25,"expiration_date":"2032-04-26","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001494650-22-000045","document":"wf-form4_165100418529600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1494650/000149465022000045/wf-form4_165100418529600.xml","form_type":"4"}},{"id":2294593,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-19T23:36:57.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":3944,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 3,944 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 3,944 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":84663,"source":{"system":"sec-edgar","filing":"0001493152-22-010476","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222010476/ownership.xml","form_type":"4"}},{"id":2297612,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-13T21:05:05.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":24844,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 24,844 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 24,844 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":80719,"source":{"system":"sec-edgar","filing":"0001493152-22-009831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222009831/ownership.xml","form_type":"4"}},{"id":2303973,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T21:03:38.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":1741,"price":9.96,"value":17340.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $9.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2022."}],"balance_after":55942,"source":{"system":"sec-edgar","filing":"0001171520-22-000233","document":"eps10159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000233/eps10159.xml","form_type":"4"}},{"id":2310040,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-04-04T21:21:17.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":7832,"price":2.87,"value":22477.84,"ownership":{"direct":true},"balance_after":109960,"source":{"system":"sec-edgar","filing":"0001161697-22-000159","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000159/form_4.xml","form_type":"4"}},{"id":2310932,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-01T20:30:41.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":43478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":55875,"source":{"system":"sec-edgar","filing":"0001493152-22-008834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222008834/ownership.xml","form_type":"4"}},{"id":2430037,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-01-21T02:22:26.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":3721,"price":1.31,"value":4874.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 18, 2022, the Reporting Person was granted 3,721 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":12397,"source":{"system":"sec-edgar","filing":"0001493152-22-001790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315222001790/ownership.xml","form_type":"4"}},{"id":2448300,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T12:16:39.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":2003,"price":11.54,"value":23114.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $11.54 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2021."}],"balance_after":54201,"source":{"system":"sec-edgar","filing":"0001171520-22-000013","document":"doc4_988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000013/doc4_988.xml","form_type":"4"}},{"id":2455546,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2022-01-03T21:20:54.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":7500,"price":3,"value":22500.0,"ownership":{"direct":true},"balance_after":102128,"source":{"system":"sec-edgar","filing":"0001161697-22-000010","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000010/form_4.xml","form_type":"4"}},{"id":2551668,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:15:19.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":1290,"price":17.92,"value":23116.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $17.92 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended October 1, 2021."}],"balance_after":52198,"source":{"system":"sec-edgar","filing":"0001420506-21-001362","document":"doc4_971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001362/doc4_971.xml","form_type":"4"}},{"id":2553394,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2021-10-04T20:11:13.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":7894,"price":2.85,"value":22497.9,"ownership":{"direct":true},"balance_after":94628,"source":{"system":"sec-edgar","filing":"0001161697-21-000468","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000468/form_4.xml","form_type":"4"}},{"id":2642858,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2021-07-06T23:15:43.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":3744,"price":4.63,"value":17334.72,"ownership":{"direct":true},"balance_after":86734,"source":{"system":"sec-edgar","filing":"0001161697-21-000328","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000328/form_4.xml","form_type":"4"}},{"id":2644127,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:16:35.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":771,"price":20.26,"value":15620.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $20.26 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2021."}],"balance_after":50908,"source":{"system":"sec-edgar","filing":"0001420506-21-000843","document":"doc4_939.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000843/doc4_939.xml","form_type":"4"}},{"id":2653234,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-06-28T12:33:06.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":6006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":6006,"derivative":{"exercise_price":19.98,"expiration_date":"2031-06-25","underlying":"Common Stock","underlying_shares":6006},"source":{"system":"sec-edgar","filing":"0001171520-21-000262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152021000262/ownership.xml","form_type":"4"}},{"id":2653233,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T12:33:06.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":3003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2022 annual meeting of stockholders."}],"balance_after":50137,"source":{"system":"sec-edgar","filing":"0001171520-21-000262","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152021000262/ownership.xml","form_type":"4"}},{"id":2698488,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-05-24T20:05:37.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":15300,"price":3.3879,"value":51834.87,"ownership":{"direct":false,"nature":"By R. John Fletcher 2015 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.47 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":30300,"source":{"system":"sec-edgar","filing":"0001493152-21-012688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315221012688/ownership.xml","form_type":"4"}},{"id":2698487,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-05-24T20:05:37.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":15000,"price":3.3299,"value":49948.5,"ownership":{"direct":false,"nature":"By R. John Fletcher 2015 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.31 to $3.34 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-21-012688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315221012688/ownership.xml","form_type":"4"}},{"id":2709453,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2021-05-18T20:17:51.000Z","date":"2021-05-17","kind":"purchase","acquired":true,"shares":25000,"price":4.3,"value":107500.0,"ownership":{"direct":true},"balance_after":82990,"source":{"system":"sec-edgar","filing":"0001161697-21-000267","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000267/form_4.xml","form_type":"4"}},{"id":2751141,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:18:48.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":738,"price":19.57,"value":14442.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $19.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2021."}],"balance_after":47134,"source":{"system":"sec-edgar","filing":"0001420506-21-000402","document":"doc4_916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000402/doc4_916.xml","form_type":"4"}},{"id":2759732,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2021-04-05T20:31:45.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":3551,"price":3.52,"value":12499.52,"ownership":{"direct":true},"balance_after":57990,"source":{"system":"sec-edgar","filing":"0001161697-21-000198","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000198/form_4.xml","form_type":"4"}},{"id":2763547,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-02T01:48:08.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":13015,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13015,"derivative":{"exercise_price":4.61,"exercise_date":"2021-03-30","expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":13015},"source":{"system":"sec-edgar","filing":"0001493152-21-007825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315221007825/ownership.xml","form_type":"4"}},{"id":2763546,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-02T01:48:08.000Z","date":"2021-03-30","kind":"other","acquired":true,"shares":10265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of August 21, 2020, as amended, by and among Cancer Genetics, Inc. now known as Vyant Bio, Inc. (\"Issuer\"), CGI Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of Issuer (\"Merger Sub\") and StemoniX, Inc., a Minnesota corporation (\"StemoniX\") (the \"Merger Agreement\"), Reporting Person received options to purchase shares of Common Stock of the Issuer in exchange for options to purchase shares of StemoniX common stock, $0.0001 owned prior to the merger. These options are fully vested."}],"balance_after":10265,"derivative":{"exercise_price":1.56,"exercise_date":"2021-03-30","expiration_date":"2030-08-01","underlying":"Common Stock","underlying_shares":10265},"source":{"system":"sec-edgar","filing":"0001493152-21-007825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315221007825/ownership.xml","form_type":"4"}},{"id":2763545,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T01:48:08.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":8676,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2021, the Reporting Person was granted 8,676 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2022, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2021, the Reporting Person was granted 8,676 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2022, so long as Reporting Person remains a director though that date."}],"balance_after":8676,"source":{"system":"sec-edgar","filing":"0001493152-21-007825","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1215024/000149315221007825/ownership.xml","form_type":"4"}},{"id":2855522,"issuer":{"id":4152,"kind":"organization","name":"AXCELIS TECHNOLOGIES INC","symbol":"ACLS"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T22:11:36.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":6881,"price":39,"value":268359.0,"ownership":{"direct":true},"balance_after":1354,"source":{"system":"sec-edgar","filing":"0001209191-21-011356","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113232/000120919121011356/doc4.xml","form_type":"4"}},{"id":2926873,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2021-01-05T00:53:07.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":3114,"price":6.02,"value":18746.28,"ownership":{"direct":true},"balance_after":54439,"source":{"system":"sec-edgar","filing":"0001161697-21-000035","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000035/form_4.xml","form_type":"4"}},{"id":2925334,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T23:37:13.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":808,"price":15,"value":12120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020."}],"balance_after":46396,"source":{"system":"sec-edgar","filing":"0001420506-21-000011","document":"doc4_895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000011/doc4_895.xml","form_type":"4"}},{"id":2963579,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-12-01T19:42:49.000Z","date":"2020-12-01","kind":"purchase","acquired":true,"shares":1275,"price":4.53,"value":5775.75,"ownership":{"direct":true},"balance_after":51325,"source":{"system":"sec-edgar","filing":"0001161697-20-000508","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000508/form_4.xml","form_type":"4"}},{"id":2963578,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-12-01T19:42:49.000Z","date":"2020-11-30","kind":"purchase","acquired":true,"shares":21052,"price":4.48,"value":94312.96,"ownership":{"direct":true},"balance_after":50050,"source":{"system":"sec-edgar","filing":"0001161697-20-000508","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000508/form_4.xml","form_type":"4"}},{"id":3017532,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-10-02T21:12:57.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":2597,"price":7.22,"value":18750.34,"ownership":{"direct":true},"balance_after":28998,"source":{"system":"sec-edgar","filing":"0001161697-20-000428","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000428/form_4.xml","form_type":"4"}},{"id":3018421,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T22:07:03.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":2124,"price":5.71,"value":12128.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020."}],"balance_after":45588,"source":{"system":"sec-edgar","filing":"0001420506-20-001030","document":"doc4_853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620001030/doc4_853.xml","form_type":"4"}},{"id":3018420,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T22:06:03.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":2124,"price":5.71,"value":12128.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020."}],"balance_after":45588,"source":{"system":"sec-edgar","filing":"0001420506-20-001027","document":"doc4_853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620001027/doc4_853.xml","form_type":"4"}},{"id":3091398,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T17:30:25.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":3411,"price":3.55,"value":12109.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.55 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2020."}],"balance_after":43464,"source":{"system":"sec-edgar","filing":"0001171520-20-000283","document":"doc4_813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000117152020000283/doc4_813.xml","form_type":"4"}},{"id":3095923,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-07-02T00:09:08.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":2088,"price":8.98,"value":18750.24,"ownership":{"direct":true},"balance_after":26401,"source":{"system":"sec-edgar","filing":"0001161697-20-000285","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000285/form_4.xml","form_type":"4"}},{"id":3106747,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-17T20:16:02.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2021 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.13,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001420506-20-000697","document":"doc4_807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000697/doc4_807.xml","form_type":"4"}},{"id":3130928,"issuer":{"id":4152,"kind":"organization","name":"AXCELIS TECHNOLOGIES INC","symbol":"ACLS"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T23:04:56.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":50750,"price":26.52,"value":1345890.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.52 to $27.34, inclusive. The reporting person undertakes to provide to Axcelis Technologies, Inc., any security holder of Axcelis Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the shares held as of May 28, 2020, 6,881 were issuable on vesting of restricted stock units granted to the director under the 2012 Equity Incentive Plan and are subject to forfeiture."}],"balance_after":8235,"source":{"system":"sec-edgar","filing":"0001209191-20-033055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113232/000120919120033055/doc4.xml","form_type":"4"}},{"id":3147561,"issuer":{"id":4152,"kind":"organization","name":"AXCELIS TECHNOLOGIES INC","symbol":"ACLS"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-15T12:50:41.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":6881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares are issuable on vesting of restricted stock units granted under the Company's 2012 Equity Incentive Plan.  Assuming continuation of service on the Board of Directors, these restricted stock units will vest on November 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of the shares held as of May 15, 2020, 6,881 were issuable on vesting of restricted stock units granted to the director under the 2012 Equity Incentive Plan and are subject to forfeiture."}],"balance_after":58985,"source":{"system":"sec-edgar","filing":"0001209191-20-029476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113232/000120919120029476/doc4.xml","form_type":"4"}},{"id":3186156,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T20:11:32.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":3396,"price":3.57,"value":12123.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019."}],"balance_after":40053,"source":{"system":"sec-edgar","filing":"0001420506-20-000359","document":"doc4_795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000359/doc4_795.xml","form_type":"4"}},{"id":3190194,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-04-01T20:50:00.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":2500,"price":7.5,"value":18750.0,"ownership":{"direct":true},"balance_after":24313,"source":{"system":"sec-edgar","filing":"0001161697-20-000138","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000138/form_4.xml","form_type":"4"}},{"id":3314807,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-01-09T22:43:54.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":2871,"price":6.53,"value":18747.63,"ownership":{"direct":true},"balance_after":21813,"source":{"system":"sec-edgar","filing":"0001161697-20-000028","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000028/form_4.xml","form_type":"4/A","original_submission_date":"2020-01-02"}},{"id":3326945,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T22:05:06.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":2445,"price":4.96,"value":12127.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019."}],"balance_after":36657,"source":{"system":"sec-edgar","filing":"0001420506-20-000009","document":"doc4_782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000009/doc4_782.xml","form_type":"4"}},{"id":3328299,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2020-01-02T21:52:30.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":1914,"price":6.53,"value":12498.42,"ownership":{"direct":true},"balance_after":20856,"source":{"system":"sec-edgar","filing":"0001161697-20-000007","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000007/form_4.xml","form_type":"4"}},{"id":3343865,"issuer":{"id":4152,"kind":"organization","name":"AXCELIS TECHNOLOGIES INC","symbol":"ACLS"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-12T21:11:35.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.2,"exercise_date":"2015-01-11","expiration_date":"2021-07-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-060205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1113232/000120919119060205/doc4.xml","form_type":"4"}},{"id":3343864,"issuer":{"id":4152,"kind":"organization","name":"AXCELIS TECHNOLOGIES INC","symbol":"ACLS"},"owners":[{"id":32085,"kind":"person","name":"FLETCHER R JOHN","position":1,"cik":"0001215024","reported_name":"FLETCHER R JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-12T21:11:35.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.4,"exercise_date":"2012-01-12","expiration_date":"2021-07-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-060205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113232/000120919119060205/doc4.xml","form_type":"4"}}],"next_cursor":"2019-12-12T21:11:35.000000Z,3343864"}